Congenital disorder of glycosylation

From WikiMD's Wellness Encyclopedia

Doichol
Error creating thumbnail:
Dolichol monophosphate
Error creating thumbnail:
Mannose-6-phosphate.svg
Error creating thumbnail:
Mannose-1-phosphate
DolicholMPM

Congenital disorder of glycosylation (CDG) is a group of rare genetic disorders that affect the process of glycosylation, which is the attachment of sugar molecules to proteins and lipids. This process is crucial for the proper functioning of many proteins and lipids in the body. CDGs can lead to a wide range of health problems, including developmental delays, neurological disorders, and organ dysfunction.

Classification[edit | edit source]

CDGs are classified based on the specific step in the glycosylation pathway that is affected. The two main types are:

Symptoms[edit | edit source]

The symptoms of CDGs can vary widely depending on the specific type and severity of the disorder. Common symptoms include:

Diagnosis[edit | edit source]

Diagnosis of CDGs typically involves a combination of clinical evaluation, biochemical testing, and genetic testing. Biochemical tests may include analysis of serum transferrin isoforms, which can reveal abnormalities in glycosylation.

Treatment[edit | edit source]

There is currently no cure for CDGs, and treatment is primarily supportive and symptomatic. Management may include:

Prognosis[edit | edit source]

The prognosis for individuals with CDGs varies widely depending on the specific type and severity of the disorder. Some individuals may have mild symptoms and a normal lifespan, while others may have severe, life-threatening complications.

Research[edit | edit source]

Ongoing research is focused on better understanding the underlying mechanisms of CDGs, developing new diagnostic methods, and exploring potential treatments.

See also[edit | edit source]

References[edit | edit source]

External links[edit | edit source]

Template:Congenital disorders of glycosylation


Contributors: Prab R. Tumpati, MD